Ferngrove Stays: Arriving 2026
Coming in 2026, Ferngrove will offer a serene sanctuary for individuals facing advanced-stage cancer—nestled just outside the vibrant town of Highlands, North Carolina. Renowned for its world-class hospitality, Highlands is home to two of the nation’s top 10 bed-and-breakfasts, alongside a charming downtown filled with exceptional restaurants, galleries, and boutique shops—all just five minutes from the stillness of Ferngrove.
Guests will stay at no cost in thoughtfully designed private cottages, each with sweeping mountain views and calming forest surroundings. These cottages feature open, vaulted living spaces with cozy fireplaces, designer kitchens, and spa-inspired baths complete with soaking tubs, walk-in showers, and private decks overlooking the national forest.
Ferngrove will offer a quiet peacefulness—a place to think, reflect, and simply breathe. Here, the noise of treatment and uncertainty can begin to fade, and healing can start with stillness. Stays will be flexible and self-guided, with optional offerings such as emotional health sessions, integrative wellness tools, and a signature six-week guided program focused on processing grief and building resilience.
Check back soon for photos and more information as we prepare to welcome our first guests in 2026.
Who Can Participate? Understanding Inclusion & Exclusion Criteria of Clinical Trials
Many clinical trials are designed for patients who have not yet started treatment, meaning some trials may offer the best first-line therapy available. Exploring clinical trial options early in your treatment journey may provide access to cutting-edge treatments before they are widely available.
Some patients mistakenly believe that clinical trials are a last resort, but waiting until standard treatments fail could disqualify you from participating in certain studies. Trials have strict inclusion and exclusion criteria to ensure the safety of participants and the validity of the data collected.
Eligibility criteria vary by study and may consider:
- Genetic mutations (e.g., a trial may require a BRCA mutation for eligibility)
- Type and stage of cancer
- Previous treatments received
- Lab test results and medical history
If you are considering a clinical trial, it is important to discuss your options with your doctor early in your diagnosis. By understanding what trials are available, you can make an informed decision about whether a breakthrough therapy could be the right option for you.
- « Previous
- 1
- …
- 4
- 5
- 6
